ST-segment elevation myocardial infarction (STEMI) remains a major cause of morbidity and mortality, with survivors facing high risk of heart failure, recurrent ischemia, and arrhythmias. Risk stratification traditionally relies on echocardiography, while cardiac magnetic resonance (CMR) is the most effective tool for predicting adverse outcomes. However, its routine use is limited by accessibility, cost, and logistical constraints. Recently, cardiac computed tomography (CCT) has evolved from an…